Cefdinir

Product NDC: 0093-4136
11-digit product format: 000934136
Labeler code: 0093
Product ID: 0093-4136_7f269e55-b085-4315-807a-e425f0189b2c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefdinir
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Teva Pharmaceuticals USA, Inc.
Application: ANDA065332
Marketing category: ANDA
Marketing start: 2007-05-08
Substance: CEFDINIR MONOHYDRATE
Active strength: 125 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065332-001	CEFDINIR	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-05-04
A065332-002	CEFDINIR	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-05-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065332-001	AB
A065332-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065332-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065332-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-04	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065332-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065332-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065332-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065332-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065332-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065332-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065332-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065332-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065332-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065332-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065332-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065332-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065332-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065332-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065332-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065332-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065332-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065332-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065332-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065332-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065332-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065332-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065332-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065332-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065332-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065332-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065332-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065332-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065332-002	AB	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefdinir
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFDINIR MONOHYDRATE	125 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6E7SN358SE	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309054	Internal RxNorm lookup
476576	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a1f49fe1-b511-4f6b-a912-8ae8662d95a5	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
d3e72f63-2c41-955f-f4ce-e90c6403e67c	Product name	2	20210729
e8e66e64-d220-99cb-44eb-0f32dc8cbda1	Product name	2	20210729
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0093-4136-64	Cefdinir	60 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	60		15
0093-4136-73	Cefdinir	100 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	100		15

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0093-4136-64	ML - Milliliter	0093-4136	852b3ef8-9e22-480d-87e5-8a9b1ab30766	1	2012-07-24
0093-4136-73	ML - Milliliter	0093-4136	8621fbc6-f208-4753-a1c5-78cee429c3aa	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFDINIR MONOHYDRATE	ACTIVE INGREDIENT	6E7SN358SE	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
CEFDINIR	ACTIVE MOIETY	CI0FAO63WC	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
ANHYDROUS TRISODIUM CITRATE	INACTIVE INGREDIENT	RS7A450LGA	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
GUAR GUM	INACTIVE INGREDIENT	E89I1637KE	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0093-4136	CEFDINIR POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA, INC.]	15	Current NDC, Legacy NDC, 2 package rows	20240305_a1f49fe1-b511-4f6b-a912-8ae8662d95a5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefdinir	CEFDINIR	Preferred Pharmaceuticals Inc.	0d1212c9-604f-4999-8f7d-e7cf300705ef	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332
Cefdinir	CEFDINIR	A-S Medication Solutions	1d58b10c-b253-4925-8681-580aa2e8ae2e	2025-08-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332
Cefdinir	CEFDINIR	NuCare Pharmaceuticals, Inc.	4ade94bb-6c39-13cd-e054-00144ff8d46c	2025-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332
Cefdinir	CEFDINIR	Teva Pharmaceuticals USA, Inc.	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	2023-02-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332 ndc (product): 0093-4136
Cefdinir	CEFDINIR	Proficient Rx LP	f22acd90-5dc4-406d-af78-5f9c3a674647	2022-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065332 application number: ANDA065332

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6E7SN358SE	CEFDINIR MONOHYDRATE	213978-34-8	CEFDINIR MONOHYDRATE
CI0FAO63WC	CEFDINIR	91832-40-5	Cefdinir

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309054	cefdinir 125 MG in 5 mL Oral Suspension	PSN	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	15
476576	cefdinir 250 MG in 5 mL Oral Suspension	PSN	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	15
309054	cefdinir 25 MG/ML Oral Suspension	SCD	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	15
476576	cefdinir 50 MG/ML Oral Suspension	SCD	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	15
309054	cefdinir 125 MG per 5 ML Oral Suspension	SY	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	15
476576	cefdinir 250 MG per 5 ML Oral Suspension	SY	a1f49fe1-b511-4f6b-a912-8ae8662d95a5	15
309054	cefdinir 125 MG in 5 mL Oral Suspension	PSN	1d58b10c-b253-4925-8681-580aa2e8ae2e	12
309054	cefdinir 25 MG/ML Oral Suspension	SCD	1d58b10c-b253-4925-8681-580aa2e8ae2e	12
309054	cefdinir 125 MG per 5 ML Oral Suspension	SY	1d58b10c-b253-4925-8681-580aa2e8ae2e	12
309054	cefdinir 125 MG in 5 mL Oral Suspension	PSN	4ade94bb-6c39-13cd-e054-00144ff8d46c	6
309054	cefdinir 25 MG/ML Oral Suspension	SCD	4ade94bb-6c39-13cd-e054-00144ff8d46c	6
309054	cefdinir 125 MG per 5 ML Oral Suspension	SY	4ade94bb-6c39-13cd-e054-00144ff8d46c	6
309054	cefdinir 125 MG in 5 mL Oral Suspension	PSN	c335ee41-a4fe-43c9-bf21-91b24992378c	3
309054	cefdinir 25 MG/ML Oral Suspension	SCD	c335ee41-a4fe-43c9-bf21-91b24992378c	3
309054	cefdinir 125 MG per 5 ML Oral Suspension	SY	c335ee41-a4fe-43c9-bf21-91b24992378c	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0093-4136-64	00093413664	60 mL in 1 BOTTLE (0093-4136-64)	60 ml	2007-05-08	0000-00-00	No	No	Current
0093-4136-73	00093413673	100 mL in 1 BOTTLE (0093-4136-73)	100 ml	2007-05-08	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefdinir for Oral Suspension, USP Rx only	A-S Medication Solutions	2025-08-13	HUMAN PRESCRIPTION DRUG LABEL	12
CEFDINIR FOR ORAL SUSPENSION USP 4136 4137 Rx only	NuCare Pharmaceuticals, Inc.	2025-02-04	HUMAN PRESCRIPTION DRUG LABEL	6
Cefdinir for Oral Suspension, USP Rx only	Teva Pharmaceuticals USA, Inc.	2023-02-01	HUMAN PRESCRIPTION DRUG LABEL	15
Cefdinir for Oral Suspension, USP Rx only	RPK Pharmaceuticals, Inc.	2023-01-01	HUMAN PRESCRIPTION DRUG LABEL	3